Tower Research Capital (TRC)’s Senti Biosciences SNTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37K | Sell |
1,121
-304
| -21% | -$641 | ﹤0.01% | 4660 |
|
|
2025
Q1 | $4.79K | Buy |
1,425
+402
| +39% | +$1.35K | ﹤0.01% | 4197 |
|
|
2024
Q4 | $3.59K | Sell |
1,023
-1,336
| -57% | -$4.69K | ﹤0.01% | 4632 |
|
|
2024
Q3 | $5.33K | Buy |
2,359
+1,977
| +518% | +$4.47K | ﹤0.01% | 4291 |
|
|
2024
Q2 | $1.06K | Sell |
382
-469
| -55% | -$1.3K | ﹤0.01% | 5216 |
|
|
2024
Q1 | $3.21K | Buy |
+851
| New | +$3.21K | ﹤0.01% | 4903 |
|
|
2023
Q3 | – | Sell |
-338
| Closed | -$2.12K | – | 6180 |
|
|
2023
Q2 | $2.12K | Buy |
+338
| New | +$2.12K | ﹤0.01% | 5222 |
|
|
2023
Q1 | – | Sell |
-2,308
| Closed | -$33K | – | 6246 |
|
|
2022
Q4 | $33K | Buy |
2,308
+1,363
| +144% | +$19.5K | ﹤0.01% | 2670 |
|
|
2022
Q3 | $21K | Buy |
945
+822
| +668% | +$18.3K | ﹤0.01% | 3905 |
|
|
2022
Q2 | $2K | Buy |
123
+52
| +73% | +$846 | ﹤0.01% | 5602 |
|
|
2022
Q1 | $7K | Sell |
71
-1
| -1% | -$99 | ﹤0.01% | 4763 |
|
|
2021
Q4 | $7K | Buy |
+72
| New | +$7K | ﹤0.01% | 4940 |
|